STRS OHIO - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
STRS OHIO ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$284
-30.2%
13,8000.0%0.00%
-50.0%
Q2 2023$407
-73.1%
13,800
-79.0%
0.00%0.0%
Q1 2023$1,512
+61.4%
65,700
+95.0%
0.00%
-50.0%
Q4 2022$937
-99.9%
33,7000.0%0.00%
-20.0%
Q3 2022$1,034,000
+4.3%
33,7000.0%0.01%
+25.0%
Q2 2022$991,000
-0.3%
33,700
+9.1%
0.00%0.0%
Q1 2022$994,000
-27.9%
30,9000.0%0.00%
-20.0%
Q4 2021$1,378,000
-11.6%
30,9000.0%0.01%
-16.7%
Q3 2021$1,558,000
-36.3%
30,900
-1.0%
0.01%
-33.3%
Q2 2021$2,447,000
+61.2%
31,200
+17.3%
0.01%
+50.0%
Q1 2021$1,518,000
-8.4%
26,600
+34.3%
0.01%0.0%
Q4 2020$1,658,000
+289.2%
19,800
+66.4%
0.01%
+200.0%
Q3 2020$426,000
+48.4%
11,9000.0%0.00%
+100.0%
Q2 2020$287,000
-50.0%
11,900
-63.7%
0.00%
-66.7%
Q1 2020$574,000
+0.5%
32,8000.0%0.00%
+50.0%
Q4 2019$571,000
-43.1%
32,800
-50.0%
0.00%0.0%
Q3 2019$1,004,000
+47.6%
65,600
+100.0%
0.00%
-33.3%
Q2 2019$680,000
+655.6%
32,800
+613.0%
0.00%
Q1 2018$90,0004,6000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders